Tag
Researchers at the University of Cambridge have developed the first entirely AI-designed vaccine, which targets entire virus families and has successfully completed a Phase I human trial showing safety and broad immune response.
Moderna received $50 million from CEPI to develop an mRNA Ebola vaccine targeting the Bundibugyo strain, amid a severe outbreak in DRC with over 1,000 cases and 241 deaths.